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Abstract
Background: Entry screening tends to start with a search for febrile international passengers, and infrared
thermoscanners have been employed for fever screening in Japan. We aimed to retrospectively assess the
feasibility of detecting influenza cases based on fever screening as a sole measure.
Methods: Two datasets were collected at Narita International Airport during the 2009 pandemic. The first
contained confirmed influenza cases (n = 16) whose diagnosis took place at the airport during the early stages of
the pandemic, and the second contained a selected and suspected fraction of passengers (self-reported or
detected by an infrared thermoscanner; n = 1,049) screened from September 2009 to January 2010. The sensitivity
of fever (38.0°C) for detecting H1N1-2009 was estimated, and the diagnostic performances of the infrared
thermoscanners in detecting hyperthermia at cut-off levels of 37.5°C, 38.0°C and 38.5°C were also estimated.
Results: The sensitivity of fever for detecting H1N1-2009 cases upon arrival was estimated to be 22.2% (95%
confidence interval: 0, 55.6) among nine confirmed H1N1-2009 cases, and 55.6% of the H1N1-2009 cases were
under antipyretic medications upon arrival. The sensitivity and specificity of the infrared thermoscanners in
detecting hyperthermia ranged from 50.8-70.4% and 63.6-81.7%, respectively. The positive predictive value
appeared to be as low as 37.3-68.0%.
Conclusions: The sensitivity of entry screening is a product of the sensitivity of fever for detecting influenza cases
and the sensitivity of the infrared thermoscanners in detecting fever. Given the additional presence of confounding
factors and unrestricted medications among passengers, reliance on fever alone is unlikely to be feasible as an
entry screening measure.
Background
The rapid international spread of severe acute respira-
tory syndrome (SARS) from 2002 to 2003 led countries
around the world to extensively assess the entry screen-
ing measures at their international borders as one of the
countermeasures to prevent the global spread of infec-
tious diseases [1,2]. Pandemic influenza has been one of
the most important subjects for entry screening [3].
Including an analysis of the historical records of mari-
time quarantine during the 1918-1919 influenza pan-
demic [4], many scientific discussions concerning the
scientific value and public health performance of entry
screening took place prior to the 2009 pandemic.
Although the efficacy of entry screening in correctly
detecting and diagnosing influenza cases is likely to be
small, mainly because of the impossibility of detecting
incubating individuals at the border [5,6] and the pre-
sence of asymptomatic cases [7-9], many countries
adopted entry screening measures to some extent during
the early stages of the 2009 pandemic [10]. Japan fol-
lowed its original guideline [11] to enforce entry screen-
ing at international airports as well as other border
control measures during the very early stages of the
2009 pandemic, with the aims of detecting influenza
cases at the border and preventing secondary transmis-
sions arising from potentially exposed individuals
through strict quarantine (e.g. at hotels close to airports)
or voluntary home quarantine.
Since the diagnostic criteria and definitions of both
SARS and influenza-like illness include fever, entry
screening tends to start with a search for febrile interna-
tional passengers, and such fever screening has tended
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because of their non-invasive nature and the need to
screen massive numbers of travelers at the border
[12-14]. Because of the relatively high sensitivity and spe-
cificity, the negative predictive value (NPV) of infrared
thermoscanners in excluding non-febrile passengers is
believed to be high [15-19], which supports the use of
infrared thermoscanners for releasing negative indivi-
duals (i.e. a strict screening measure through diagnosis
by exclusion), under an important assumption that the
prevalence of infected individuals is small among the
total number of passengers and with the expectation that
“cases” are represented as febrile passengers. Although
border control does not fully rely on infrared thermo-
scanners to detect febrile passengers, Narita International
Airport (also known as Tokyo-Narita Airport or New
Tokyo International Airport), comprising the largest
international airport in Japan and dealing with 58% of
arriving international passengers, has placed stationary
infrared thermoscanners as an aid to monitor and screen
for fever among arriving international passengers since
2003. However, despite the high diagnostic accuracy and
NPV under the above-mentioned assumption and expec-
tation, the readings of infrared thermoscanners are
known to be influenced by several confounding factors
including age and outdoor temperature, and the small
positive predictive value (PPV) with the small prevalence
of febrile passengers is not believed to realistically permit
less strict entry screening (e.g. use of infrared thermo-
scanners to actively detect hyperthermia) [20-22]. The
validity of fever screening in relation to its theoretical
rationale (e.g. the above-mentioned assumption and
expectation) should be assessed in practical settings.
Japan is one of the countries that implemented the
most strict entry screening during the early stages of the
2009 pandemic [10]. This allowed us to retrospectively
analyze epidemiological datasets of confirmed cases
whose diagnosis took place at an international border
during the early entry screening practice and of a por-
tion of passengers screened by the infrared thermoscan-
ners. The datasets of the influenza cases and passengers
provide us with a unique opportunity to critically inves-
tigate the public health performance of fever screening
in correctly detecting and diagnosing influenza (H1N1-
2009) at international borders. The purpose of the pre-
sent study was to retrospectively assess the feasibility of
detecting influenza cases based on fever screening as a
sole measure through the analysis of actual entry screen-
ing data, thereby identifying practical issues surrounding
fever screening of passengers including influenza cases.
Methods
In the present study, we analyzed two different datasets
collected at Narita International Airport, which receives
approximately 87,000 international flights per year (i.e.
240 flights per day) and through which approximately
18 million passengers per year enter Japan (i.e. 40,000-
50,000 passengers per day) including Japanese passen-
gers returning from abroad. The first dataset contained
the limited number of confirmed cases infected with
H1N1-2009 or other influenza viruses whose diagnosis
took place at the airport during the very early stages of
the 2009 pandemic, and the second dataset contained
non-randomly sampled passengers, comprising a
selected and suspected fraction of passengers (self-
reported or detected by an infrared thermoscanner)
arriving at Narita International Airport from September
2009 to January 2010 (Figure 1).
Confirmed cases
The first dataset was based on strict entry screening
measures implemented from 28 April to 18 June 2009,
which targeted passengers arriving from Canada, Mexico
and the United States. The strictest border control mea-
sures (i.e. those involving fever screening of passengers
on board before disembarkation from an arriving air-
craft) were performed until 21 May. From 22 May to 18
June, a clinical examination and laboratory testing were
performed for self-reporting passengers and those
detected by the stationary infrared thermoscanners. Pas-
sengers with a travel history to the above-mentioned
three countries with fever greater than 38.0°C (directly
measured by the tympanic or axillary temperature, for
example) or with two or more acute upper respiratory
tract symptoms (e.g. cough, sputum or breathlessness)
underwent rapid diagnostic testing for influenza. Briefly,
nasal swab specimens were taken for the rapid diagnos-
tic testing and, if positive for influenza type A virus, a
confirmatory diagnosis was made by RT-PCR. The pri-
mers for real-time RT-PCR for H1N1-2009 detection
were developed by the National Institute of Infectious
Diseases and became available on 29 April 2009 [23].
During the 52-day screening period, a total of 1,903
commercial aircrafts landed at Narita International Air-
port from the three countries bringing 441,041 passen-
gers and 30,692 airline crew members [24]. Among
these, 805 persons underwent rapid diagnostic testing,
and 15 tested positive. Including those who tested nega-
tive but were strongly suspected of having the disease
(e.g. those with a history of apparent contact with a
known case), a total of 18 cases were confirmed as hav-
ing influenza (Figure 1). Among these cases, 10 had
H1N1-2009, 7 had other influenza type A virus subtypes
(four with H3 and three with H1 other than H1N1-
2009) and one had influenza type B virus. One of the 10
H1N1-2009 cases was healthy upon arrival, but had a
history of contact with other symptomatic cases. Since
this case developed the illness during quarantine at a
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temperature of one H3 case upon arrival was unknown.
Accordingly, a total of 9 cases with H1N1-2009 and 7
cases with other influenza viruses with data regarding
age, gender, history of medications prior to arrival and
axillary temperature upon arrival were evaluated.
Screened passengers
The other dataset included data for axillary temperature,
surface temperature measured by an infrared thermo-
scanner and other variables among a total of 1,049 pas-
sengers arriving at Narita International Airport from 1
September 2009 to 31 January 2010. During the 5-
month study period, a total of 9,140,435 passengers
entered Japan through Narita International Airport, and
all were screened by infrared thermoscanners. A total of
eight TVS-500 infrared thermoscanners (NEC/AVIO
Infrared Technologies Co. Ltd., Tokyo, Japan) were
placed near the quarantine station before immigration.
The infrared sensors optically scanned the surface of
each passenger, and the temperature distributions were
recorded as two-dimensional thermal images. Our sub-
jects comprised a selected and suspected fraction of pas-
sengers among the total passengers, who fulfilled one of
the following selection criteria: (a) those who self-
reported some symptom or actively visited the health
consultation room of the quarantine station; (b) relatives
or friends of self-reporting individuals; or (c) those who
were detected by an infrared thermoscanner (based on a
predefined threshold reading of 35.4°C) and were asked
by quarantine officers to undergo further examinations.
Hereafter, we refer to these 1,049 passengers as the
“selected and suspected fraction” of passengers, because
the passengers were selected based on the above-men-
tioned criteria and were more likely to be suspected of
fever than the remaining passengers.
Figure 2 shows a map of Narita International Airport,
which employs a satellite terminal design (i.e. an airport
building detached from other airport buildings so that
aircraft can park around its entire circumference). There
are two terminals, namely Terminal 1 with four satellites
and Terminal 2 with two satellites. These satellites can
be crudely classified into three areas, and each is utilized
by a single alliance of airline companies. Four infrared
thermoscanners were set up in each terminal. The dis-
tances between the infrared thermoscanners and the
passengers varied slightly in the satellites, being 4-19 m
in Terminal 1 and 3-10 m in Terminal 2.
Guided by quarantine officers, all the subjects volunta-
rily entered the health consultation room. Upon
entrance, the axillary temperature of the subjects was
measured once using a C202 axillary thermometer
(Termo Corporation, Tokyo, Japan). The sensor was
directly inserted into the axilla, and the temperature was
measured by a thermistor. The temperature was dis-
played at approximately 90 seconds after the insertion.
Figure 1 Flow chart of participants in the study. Two datasets were collected at Narita International Airport. The first contained confirmed
influenza cases whose diagnosis took place at the airport during the early stages of the pandemic (Study A). The second contained a selected
and suspected fraction of passengers (self-reported or detected by an infrared thermoscanner) screened from September 2009 to January 2010
(Study B).
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regarding age, gender, aircraft (i.e. place of embarka-
tion), self-reporting (i.e. presence or absence of volun-
tary reporting of any symptoms) and information of the
satellite where the surface temperature was measured by
an infrared thermoscanner (i.e. alliances A, B or C).
Since air-conditioning greatly influences room tempera-
ture variations within the airport, and because the room
temperature also varies with arrival gates and satellites
(e.g. depending on individual routes of entry), we were
not able to measure the room temperature for each sub-
ject. History of medications prior to the screening was
not collected systematically.
Statistical analysis
For both datasets, we used the axillary temperature as a
reference variable, and axillary temperatures above
defined thresholds were considered to be hyperthermia
(our outcome variable). First, we documented the sum-
mary statistics of the demographic variables and axillary
temperatures for both datasets. Second, using the first
dataset, we examined the sensitivity of fever for detect-
ing influenza among the sample of confirmed cases, by
using three different cut-off levels for defining
hyperthermia (37.5°C, 38.0°C and 38.5°C) based on the
axillary temperature upon arrival. Because the sample
size was small, we computed the exact 95% confidence
interval (CI) of the sensitivity, using the quantile func-
tion of the binomial distribution. We also examined the
associations between hyperthermia and types of influ-
enza virus (H1N1-2009 or not), age, gender and history
of medications.
Third, among the 1,049 screened passengers, we mea-
sured the associations of hyperthermia with age, gender,
place of embarkation (categorized into six regions of
the World Health Organization, but grouping South-
east-Asia and Western Pacific regions into one region
owing to their geographic closeness), self-reporting
(dichotomous) and satellite of measurement (categorized
by three areas as shown in Figure 2). Except for the
axillary temperature and the surface temperature mea-
sured by an infrared thermoscanner, only age was a
continuous variable. We employed the Welch test to
examine the association between hyperthermia and age.
For all the remaining variables, we used Fisher’se x a c t
test or the c
2 test.
Fourth, we assessed the univariate correlation and
association between the axillary temperature (outcome
variable) and the surface temperature measured by an
infrared thermoscanner. Pearson’s product-moment cor-
relation was employed to examine the correlation
between two continuous variables. Subsequently, the
diagnostic performances (including sensitivity, specificity
and area under the receiver operating characteristic
curve (AUC)) of the infrared thermoscanners were esti-
mated along with the PPV and NPV. We employed the
Youden index (i.e. sensitivity plus specificity minus 1) to
identify the sensitivity and specificity of the infrared
thermoscanners at an optimal threshold of the surface
temperature. The 95% CIs of the sensitivity and specifi-
city were computed using normal approximation to the
binomial distribution, while the calculations of the 95%
CIs of the PPV and NPV were based on the Wald
method with the PPV and NPV variances determined by
the delta method [25]. For calculation of the 95% CI of
the AUC, we employed the Wald method using logit
transformation of the AUC [26]. Lastly, we measured an
adjusted AUC by incorporating a demographic variable
that appeared to be a potential confounding factor of
hyperthermia (i.e. age) by employing a multiple logistic
regression. Since our selection criterion (c) for the 1,049
passengers already included those detected by the ther-
moscanners, we also assessed the above-mentioned diag-
nostic performances of the thermoscanners in
identifying fever among the sample of self-reporting pas-
sengers only.
Ethical considerations
The study conformed to the principles of the Helsinki
Declaration. Eligible subjects were voluntarily enrolled,
and informed consent was obtained before the enrollment.
Figure 2 Simplified map of Narita International Airport.T h e
airport has two discrete terminals. A total of four infrared
thermoscanners were placed in each terminal. Terminal 2 is mostly
used by alliance A, while Terminal 1 is roughly divided into two
groups of satellites used by alliances B and C, respectively. The
stationary infrared thermoscanners were set up near the quarantine
station before immigration.
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practice following the guideline of the Japan Pandemic
Influenza Plan issued by the Government of Japan [11].
The fever screening, health examination and laboratory
testing were conducted according to the Quarantine Act
(Articles 12 and 13), and the use of the infrared thermo-
scanners and examination of axillary temperature adhered
to the Health Service Bureau Notice issued by the Tuber-
culosis and Infectious Disease Control Division of the
Ministry of Health, Labour and Welfare of Japan. The ana-
lysis of the data and its publication are permitted by Arti-
cle 27-2 of the Quarantine Act. No names (only ID
numbers) were assigned to each study participant and the
data were anonymously analyzed.
Results
Fever among confirmed cases (n = 16)
The mean (standard deviation (SD)) age of all the con-
firmed cases was 30.5 (16.4) years. The ages did not dif-
fer significantly between patients with H1N1-2009 and
the other influenza viruses (p = 0.11). Males accounted
for 9 cases (56.3%), and gender was not significantly
associated with H1N1-2009 (p = 0.13). A total of 13
cases (81.3%) were under medications upon arrival. Five
of the 9 H1N1-2009 cases (55.6%) had taken commer-
cially available cold/cough medications containing anti-
pyretic substances, and one child case among the
remaining four cases took an antibiotic (azithromycin)
prior to arrival. These medications were started at 20
hours to 2 days before arrival. All 7 cases with the other
influenza viruses were under medications: five with
commercially available cold/cough medications contain-
ing antipyretic substances, one with oseltamivir and one
with an antibiotic (cefcapene pivoxil hydrochloride).
Medications were not significantly associated with
H1N1-2009, when the antibiotics were both included
and excluded (p = 0.21 and p = 0.31, respectively).
Among the 9 confirmed cases with H1N1-2009, the
axillary temperature upon arrival ranged from 36.6-38.5°
C with a mean (SD) of 37.2°C (0.7°C). The axillary tem-
perature of the cases with the other influenza viruses
ranged from 35.0-39.6°C with a mean (SD) of 37.3°C
(1.5°C). The axillary temperature did not differ signifi-
cantly between the two groups (p = 0.95; Figure 3), and
the proportions of hyperthermia also did not differ sig-
nificantly between the two groups for the cut-off levels
of 37.5°C, 38.0°C and 38.5°C (p > 0.05 for all cut-off
levels). For the cut-off levels of both 37.5°C and 38.0°C,
the sensitivities of hyperthermia for detecting influenza
were estimated to be 22.2% (95% CI: 0, 56.0) for H1N1-
2009 and 42.9% (95% CI: 14.3, 85.7) for the other influ-
enza viruses. Using 38.5°C as the cut-off level, the sensi-
tivities were estimated to be 11.1% (95% CI: 0, 33.3) for
H1N1-2009 and 28.6% (95% CI: 0, 57.1) for the other
influenza viruses. Age and gender were not significantly
associated with the proportion of hyperthermia cases
among the total of 16 confirmed influenza cases using
all three cut-off levels (p > 0.05 for all cut-off levels).
Medications were also not associated with hyperthermia
among the 16 cases, when the antibiotics were both
included and excluded (p > 0.05 for all cut-off levels).
Among the 9 cases with H1N1-2009, medications were
not significantly associated with hyperthermia (p > 0.05
for all cut-off levels), but the proportion of hyperthermia
cases was smaller among those with medications for the
cut-off levels of 37.5°C and 38.0°C. For both cut-off
levels, the sensitivities of fever for detecting influenza
were 16.7% (95% CI: 3.0, 56.4) and 33.3% (95% CI: 6.1,
79.2) among those with and without medications
(including antibiotics), respectively.
Fever among screened passengers
The age distribution of the 1,049 subjects is shown in
Figure 4A. The mean (SD) and median (lower to upper
quartiles) ages were 30.3 (18.5) and 29 (20-42) years,
respectively. Males accounted for 653 persons (62.7%).
Regarding the place of embarkation, 788 cases (75.1%)
were from countries belonging to Western Pacific or
Southeast Asian regions, 144 (13.7%) were from the
Americas, 83 (7.9%) were from Europe and 34 (3.3%)
were from the Eastern Mediterranean region, Africa or
Figure 3 Distribution of the axillary temperatures among the
confirmed influenza cases. The axillary temperatures upon arrival
were compared between the cases with H1N1-2009 (n = 9) and the
cases with other influenza viruses (n = 7). The confirmed cases
represent patients whose diagnosis took place at Narita
International Airport from 28 April to 18 June 2009. Unfilled symbols
represent passengers without medications upon arrival and filled
symbols represent passengers with medications. The horizontal
dashed line is the reference line of 38.0°C, above which cases may
be regarded as having hyperthermia.
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some symptoms, and 930 persons (88.7%) were detected
by an infrared thermoscanner (Figure 1). Self-reporting
individuals with positive screening results by an infrared
thermoscanner accounted for 185 cases (64.9% of all
self-reporting individuals). Alliances A, B and C
accounted for 574, 362 and 113 passengers, respectively.
The mean (SD) axillary temperature was 37.6°C (1.0°
C). The proportions of cases with hyperthermia using
the cut-off levels of 37.5°C, 38.0°C and 38.5°C were
51.9% (95% CI: 48.8, 54.9), 37.0% (95% CI: 34.1, 40.0)
and 23.5% (95% CI: 21.1, 26.2), respectively. The mean
(SD) temperature measured by the infrared thermoscan-
ners was 36.3°C (0.9°C). During the period of observa-
tion, no confirmatory diagnoses of H1N1-2009 were
made among the total screened passengers (i.e. includ-
ing passengers who were not included in our study).
Overall, 28 persons were diagnosed with malaria, and 30
and 15 were diagnosed with dengue virus infection and
chikungunya virus infection, respectively.
The axillary temperature tended to be higher among
younger passengers (Pearson’s correlation coefficient =
-0.198, p < 0.01; Figure 4B). Using the cut-off levels of
37.5°C, 38.0°C and 38.5°C, the ages of the passengers
with hyperthermia appeared to be significantly younger
than those without fever (p < 0.01 for all cut-off levels).
There was no gender-specificity in the proportions of
hyperthermia for the cut-off levels of 38.0°C and 38.5°C
(p = 0.08 and p = 0.15, respectively), whereas gender-
specificity was observed for the cut-off level of 37.5°C (p
= 0.005; odds ratio of being male with hyperthermia =
0.7 (95% CI: 0.5, 0.9)). Place of embarkation was not sig-
nificantly associated with hyperthermia (p > 0.05 for all
cut-off levels). Self-reporting was not significantly asso-
ciated with hyperthermia for the cut-off levels of 38.0°C
and 38.5°C (p > 0.05 for both), but was significantly
associated for the cut-off level of 37.5°C (p = 0.03; odds
ratio of being a self-reporting passenger with hyperther-
mia = 0.7 (95% CI: 0.6, 1.0)), perhaps reflecting the fact
that passengers without self-reporting were more likely
to be febrile owing to our selection by employing infra-
red thermoscanners. Satellite was associated with the
proportion of hyperthermia (p < 0.01 for all cut-off
levels), but the significant association disappeared after
adjustment for age using a multiple logistic regression
(data not shown).
Identification of febrile passengers using infrared
thermoscanners
In a comparison of the axillary temperatures and the
surface temperatures measured by the infrared thermo-
scanners, the Pearson’s correlation coefficient was esti-
mated to be 0.44 (p < 0.01). As shown in the scatter
plot in Figure 5A, the variances of both measurements
were large. Using the three cut-off levels for hyperther-
mia, the surface temperatures measured by the infrared
Figure 4 Age distribution and correlation of age with axillary temperature among the screened passengers (n = 1,049). (A) Age
distribution of the screened passengers from 1 September 2009 to 31 January 2010. The screened passengers represent those who fulfilled one
of the following selection criteria: (a) those who self-reported some symptom or actively visited the health consultation room of the quarantine
station; (b) relatives or friends of self-reporting individuals; or (c) those who were detected by an infrared thermoscanner (based on a predefined
threshold reading of 35.4°C). (B) Scatter plot of the axillary temperatures as a function of the age of the screened passengers. The straight line is
a fitted line by means of a least squares regression (prediction = 37.9-0.011x, where x is the passenger age). The adjusted coefficient of
determination, R
2, is 0.038.
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defined as having hyperthermia (p < 0.01 for all cut-off
levels). Table 1 shows the diagnostic performances of
the infrared thermoscanners in identifying fever at each
cut-off level. Using the cut-off levels of 37.5°C, 38.0°C
and 38.5°C, the sensitivities were estimated to be 58.3%,
50.8% and 70.4% and the specificities were estimated to
be 70.5%, 81.7% and 63.6%, respectively. The PPV and
NPV ranged from 37.3-68.0% and 61.1-87.5%, respec-
tively. The PPV was smallest (37.3%) for the cut-off
level of 38.5°C, while the NPV was smallest (61.9%) for
the cut-off level of 37.5°C. The receiver operating char-
acteristic (ROC) curves for the 1,049 subjects with the
three different cut-off levels are shown in Figure 5B.
The expected AUC values ranged from 70.5-73.9%, and
were much smaller than those in previously published
studies [15,18]. Table 1 also summarizes the estimated
AUC values after adjustment for age. The adjustment
o f f e r e do n l ys l i g h ti m p r o v e m ents, and the age-adjusted
AUC ranged from 74.0-75.9%.
We also measured the diagnostic performances of the
infrared thermoscanners in correctly detecting fever
Figure 5 Relationship between the axillary temperature and the surface temperature measured by an infrared thermoscanner. (A, C)
Scatter plots examining the correlations between the surface temperature measured by an infrared thermoscanner and the axillary temperature.
The straight line represents a fitted line by means of a least squares regression. The adjusted coefficients of determination, R
2, were estimated to
be 0.196 and 0.296 for the data shown in (A) and (C), respectively. (B, D) Comparison of the receiver operating characteristic curves showing the
relationships between sensitivity (true positives) and 1-specificity (true negatives) in determining the diagnostic performances of the infrared
thermoscanners for predicting three different thresholds of hyperthermia definitions (37.5°C, 38.0°C and 38.5°C) based on the axillary
temperature. Panels A and B show the data for all the screened passengers (n = 1,049), while panels C and D show the data for the self-
reporting passengers only (n = 285).
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scatter plot is shown in Figure 5C, and the Pearson’s
correlation coefficient was estimated to be 0.54 (p <
0.01), which was slightly greater than that for the total
screened subjects. The estimated sensitivity and PPV
were also higher than those of the total screened sub-
jects (ranging from 73.8-81.1% and 47.9-69.9%, respec-
tively), whereas the specificity and NPV were only
partially significantly different compared with those for
the total screened passengers (Table 1). The ROC curves
for the 285 self-reporting passengers are shown in
Figure 5D. Despite small improvements, the expected
AUC values were as low as 79.5-82.9%. Although the
passengers defined as having hyperthermia were signifi-
cantly younger among the self-reporting passengers (p =
0.003, p = 0.026 and p = 0.004 for the cut-off levels of
37.5°C, 38.0°C and 38.5°C, respectively), adjustment for
age did not result in apparent improvement of the esti-
mated AUC (74.0-78.8%).
Discussion
The present study analyzed epidemiological datasets of
confirmed influenza cases whose diagnosis took place at
Narita International Airport during the early stages of
the 2009 pandemic and of a selected and suspected frac-
tion of passengers screened from September 2009 to
January 2010. In our retrospective assessments of the
diagnostic performances of fever screening in detecting
and diagnosing influenza at the main entrance airport to
Japan, three key findings appeared to be notable. First,
despite the small sample size, the sensitivity of fever (e.
g. 38.0°C) for detecting H1N1-2009 upon arrival was
estimated to be as low as 22.2% among the confirmed
cases with H1N1-2009. In addition, 5 of the 9 confirmed
cases with H1N1-2009 (55.6%) were under antipyretic
medications upon arrival. Second, the estimates of the
diagnostic performances of the infrared thermoscanners
in identifying fever among the selected and suspected
fraction of passengers were smaller than those in pre-
viously published studies, in which the samples were
mostly general populations based on prospective study
designs and/or under ideal study conditions
[15,16,21,22,27]. For example, the sensitivity and AUC
for the cut-off level of 38.0°C in the present study were
as low as 50.8% and 72.4%, respectively. Third, even
though we examined a suspected fraction of passengers
as our subjects (i.e. those who were theoretically more
likely to be febrile than the remaining passengers), the
PPV still appeared to be as low as 37.3-68.0%. Consider-
ing the total passengers arriving at Narita International
Airport, the actual PPV will be smaller than our esti-
mates (owing to the smaller prevalence of hyperther-
mia), implying more false-positive passengers during
mass screening if one relies on infrared thermoscanners
for active detection of hyperthermia [21]. In summary,
our retrospective study demonstrates that reliance on
fever alone is unlikely to be feasible as an entry screen-
ing measure.
The most important caveat of the present study is that
there are two independent processes when considering
the diagnostic performances of fever screening at an
international border [28]. The first is the sensitivity of
fever for detecting influenza cases. Although influenza-
like illness (e.g. defined as a temperature higher than
37.8°C plus either cough or sore throat) can be accu-
rately found by clinical examinations, it is known that
the clinical findings do not permit the confirmation or
exclusion of the diagnosis of influenza [29,30]. Whereas
the sensitivity of fever alone is undoubtedly higher than
that of influenza-like illness and fever screening may be
useful for avoiding a substantial number of false-nega-
tives [31], more critical studies on influenza-like illness
have indicated that a high temperature (37.8°C or
higher) is not the prime indicator of influenza [32,33].
Thus, even with these facts alone, it is evident that
active identification of influenza cases by fever screening
alone is unlikely to be feasible. In addition, our
Table 1 Estimated diagnostic performances of the
infrared thermoscanners in predicting hyperthermia
measured by the axillary temperature
Cut-off level of axillary temperature




† 51.9 (48.8, 54.9) 37.0 (34.1, 39.9) 23.5 (21.0, 26.1)
Sensitivity 58.3 (54.1, 62.4) 50.8 (45.8, 55.7) 70.4 (64.8, 76.1)
Specificity 70.5 (66.5, 74.5) 81.7 (78.7, 84.6) 63.6 (60.3, 66.9)
Positive predictive
value
68.0 (64.7, 71.3) 61.9 (57.5, 66.4) 37.3 (34.5, 40.2)
Negative predictive
value
61.1 (58.3, 63.8) 73.9 (71.8, 75.9) 87.5 (85.3, 89.7)
AUCunadj
‡ 70.5 (67.7, 73.2) 72.4 (69.6, 75.0) 73.1 (70.4, 75.7)
AUCadj




† 46.3 (43.3, 49.3) 46.3 (43.3, 49.3) 21.4 (18.9, 23.9)
Sensitivity 75.8 (68.4, 83.1) 81.1 (74.4, 87.7) 73.8 (62.7, 84.8)
Specificity 71.9 (64.8, 79.0) 65.3 (57.7, 72.8) 78.1 (72.7, 83.5)
Positive predictive
value
69.9 (64.2, 75.6 66.8 (61.7, 72.0) 47.9 (40.7, 55.1)
Negative predictive
value
77.5 (71.9, 83.0) 80.0 (74.0, 85.9) 91.6 (88.3, 94.9)
AUCunadj
‡ 79.5 (74.4, 83.7) 78.3 (73.1, 82.7) 82.9 (78.1, 86.8)
AUCadj
‡ 78.8 (73.7, 83.1) 75.0 (69.7, 79.7) 74.0 (68.6, 78.7)
All the values are expressed as percentages.
†Proportion of subjects whose
axillary temperature was above the specified cut-off level;
‡AUCunadj, area
under the receiver operating characteristic curve without adjustment for age;
AUCadj, age-adjusted estimate of the area under the receiver operating
characteristic curve. Values in parentheses are the 95% confidence intervals.
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lize that the axillary temperature tends to be readily
modified by commercial medications (e.g. antipyretics)
in practical settings. Although the proportion of febrile
cases among confirmed H1N1-2009 cases was reported
to be 94% in the United States [34], no direct compari-
son can strictly be made because the fraction of febrile
cases at an international border is different from that
among a total number of confirmed cases in a commu-
nity. However, that figure of 94% and the figure of
22.2% obtained in our study indicate that the antipyretic
medications taken by our study participants potentially
reduced the risk of fever by 76.4%.
Second, even though the diagnostic performances of
the infrared thermoscanners in detecting fever were not
sufficiently high, the prevalence of hyperthermia would
be very small among the total number of international
passengers, and thus the PPV would be considerably
lowered [20,21]. The finding our study adds to the lit-
erature on this point is that the PPV of infrared thermo-
scanners was still insufficient for actively detecting
febrile passengers, even when our interest was restricted
to a suspected fraction of passengers. The sensitivity of
entry screening in correctly detecting and diagnosing
symptomatic influenza is measured by the product of
the above-mentioned two different sensitivities [28], i.e.
the sensitivity of fever for detecting influenza cases and
the sensitivity of a non-invasive device for detecting feb-
rile passengers. The PPV of entry screening is therefore
smaller than that of the infrared thermoscanners alone.
Of course, a confirmatory diagnosis of influenza is
further required to account for the limited sensitivity of
the rapid diagnostic testing. The present study does not
criticize the use of infrared thermoscanners, but does
e m p h a s i z et h a tr e l i a n c eo ni t su s ed u r i n gt h ee n t r y
screening of influenza is unlikely to be feasible. Such
devices could be used for other purposes (e.g. estimation
of true prevalence based on known estimates of sensitiv-
ity and specificity among the total passengers) or in
other settings (e.g. screening of fever in a setting with a
far greater prevalence of hyperthermia), because infrared
thermoscanners improve the detection of fever and are
especially useful in settings where the PPV and NPV do
not matter [35].
Our estimates of the diagnostic performances must be
interpreted with caution (Table 1). The analyses of our
second dataset were based on a retrospective non-ran-
dom sample that was considered to represent a sus-
pected fraction of passengers. In other words, the
estimated sensitivity and specificity are not applicable to
other passengers owing to the imposed selection criteria,
a n di n s t e a da r eo n l yu s e f u lf o rt h es a m p l ep o p u l a t i o n
that we examined. Nevertheless, given the previous
reports of the sensitivity and specificity among a wider
spectrum of the population [20,21,27], this point should
not be regarded as a negative aspect. The scientific
value of our retrospective study was to demonstrate that
the diagnostic performances of infrared thermoscanners
in detecting febrile passengers, especially the sensitivity,
can be even worse among the suspected fraction of pas-
sengers than among all the passengers. In addition to
previous studies indicating that the use of infrared ther-
moscanners for fever screening prior to voluntary self-
reporting was not fully justified [20-22], our study has
demonstrated that infrared thermoscanners were not
useful for actively detecting fever, even among a selected
and suspected fraction of passengers. Our investigation
of a selected and suspected fraction of passengers only,
especially with the inclusion of those detected by the
infrared thermoscanners, could partly provide a reason
for the small estimates of the specificity. For example,
owing to the representation of the suspected fraction of
passengers, there were not many subjects with low axil-
lary temperatures among our subjects, thereby leading
to small estimates of the specificity compared with all
arriving passengers. Since the inclusion of cases detected
by the infrared thermoscanners in our samples compli-
cates an explicit interpretation of our estimates, we also
examined the diagnostic performances only among the
self-reported cases. The estimates of PPV and NPV
among the self-reporting passengers did not differ sig-
nificantly from those among our total subjects.
In addition to the limited diagnostic performance of
fever screening in identifying febrile influenza cases, it
should be remembered that the readings of infrared
thermoscanners are known to be influenced by other
confounding factors, most notably by age and outdoor
temperature [15,20-22]. Although we were not able to
adjust for room temperature owing to its variation
depending on air-conditioning and individual routes (e.
g. gate and satellite combinations), age was shown to be
a confounding factor, even among the suspected fraction
of passengers. There are two plausible explanations for
these findings: (a) physiological reasons including age-
dependent vascular reactivity (e.g. the temperature varies
more easily among children than among elderly persons)
[36] and (b) influenza H1N1-2009 has mainly been
observed in younger individuals, most notably among
school-age children [37-40]. Although no confirmatory
diagnoses of H1N1-2009 were made during the screen-
ing from September 2009 to January 2010, it is likely
that substantial numbers of undetected cases were
allowed into Japan during the study period [41]. The
above-mentioned point (b) poses a technical challenge,
because the real-time dependence of age on the epide-
miology of influenza introduces a time-dependency in
its influence on the readings of the infrared thermoscan-
ners (i.e. a simple statistical adjustment does not hold in
Nishiura and Kamiya BMC Infectious Diseases 2011, 11:111
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Page 9 of 11such instances). As an additional complication but per-
haps one of the most important features among interna-
tional passengers, our experience at Narita International
Airport led us to realize that the use of antipyretics and
antivirals is very likely among febrile passengers in prac-
tical settings, thereby greatly complicating the detection
owing to masked symptoms. Among those with any sus-
picious symptoms, it is natural that medications with
commercially available antipyretics are widely used with-
out any restrictions, and the different timings, doses and
medicines do not permit us to adjust for the influence
by statistical modeling.
Except for cases of imminent public health risk, the
revised International Health Regulations (IHR) in 2005
were intended to minimize interference with world tra-
vel, permitting only non-invasive and least intrusive
medical examinations that could achieve a “public health
objective” [42]. Although infrared thermoscanners are
non-invasive and may detect a small portion of febrile
influenza cases among the total passengers, our study
has demonstrated fundamental problems in the reliance
on fever in detecting and diagnosing influenza in inter-
national passengers. In addition to the issue of screen-
ing, the effectiveness of entry screening involves the
presence of incubating individuals [5,43] and asympto-
matic cases [7,8]. Given the limited information that we
can gain from fever alone, one could further examine
other vital signs to improve the detection during mass
screening [44], along with efforts to promote self-report-
ing and improve its coverage. In addition to such
devices, it is vital to reconsider the public health objec-
tives of entry screening measures with a specific disease
in mind (e.g. influenza) [45], and the way forward
requires us to explicitly define the roles and purposes of
international border control in the event of the next
pandemic [46].
Conclusions
To retrospectively assess the feasibility of detecting the
cases of influenza (H1N1-2009) based on fever screening
as a sole measure in a practical setting, we analyzed epi-
demiological datasets of confirmed influenza cases
whose diagnosis took place at Narita International Air-
port during the early stages of the 2009 pandemic and
of a selected and suspected fraction of passengers
screened from September 2009 to January 2010. Among
the confirmed H1N1-2009 cases (n = 9), the sensitivity
of fever for detecting influenza upon arrival appeared to
b ea sl o wa s2 2 . 2 % ,a n d5o ft h e9c a s e s( 5 5 . 6 % )w e r e
under antipyretic medications. The PPV of the infrared
thermoscanners for detecting fever among the suspected
fraction of passengers (n = 1,049) was shown to be
insufficient to actively detect febrile influenza cases
among passengers. Given the additional presence of
confounding factors and unrestricted medications
among passengers, the reliance on fever alone is unlikely
to be feasible as an entry screening measure against
influenza.
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